In a xenografted nude mouse model of NUGC4 cells, AMD3100 is confirmed to reduce both peritoneal carcinomatosis and malignant ascites formation, which indicates novel therapeutic implications of CXCR4 antagonists in peritoneal metastasis of GC 17. Here, CXCR4 is linked to cancer.